Experimental and laboratory reportTechnetium-99m Stannous pyrophosphate (cas 15578-26-4) myocardial scintigrams in pericardial disease☆
-
Add time:09/03/2019 Source:sciencedirect.com
Technetium-99m Stannous pyrophosphate (cas 15578-26-4) (99mTc-PYP) myocardial scintigrams were obtained in 35 acute pericarditis and in three chronic constrictive pericarditis patients. Thirteen of 35 acute pericarditis patients (37%) and one of three chronic constrictive pericarditis patients (33%) had abnormal scintigrams (a diffuse pattern in eight patients and a regional pattern in six patients). Of the 17 acute pericarditis patients with classic ST-segment changes of acute pericarditis, 10 (56%) had abnormal scintigrams compared to three of 17 patients (18%) without these ECG change (P < 0.02). These data indicate that pericardial disease may cause an abnormal scintigram. Therefore, one must rule out pericardial disease before concluding that a positive scintigram is due to acute myocardial infarction.
We also recommend Trading Suppliers and Manufacturers of Stannous pyrophosphate (cas 15578-26-4). Pls Click Website Link as below: cas 15578-26-4 suppliers
Prev:NOTESStannous-Ion Quantitation in Pyrophosphate and Polyphosphate Radiopharmaceutical Kits Using Differential Pulse Polarography
Next:Determination of the optimal concentrations of Stannous pyrophosphate (cas 15578-26-4) for in vivo red blood cell labelling with technetium-99m) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Clinical studyPrognostic value of a persistently positive technetium-99m Stannous pyrophosphate (cas 15578-26-4) myocardial scintigram after myocardial infarction09/07/2019
- Experimental StudyMechanisms contributing to myocardial accumulation of technetium-99m Stannous pyrophosphate (cas 15578-26-4) after coronary arterial occlusion*09/06/2019
- Experimental and laboratory reportValue and limitations of technetium-99m Stannous pyrophosphate (cas 15578-26-4) in the detection of acute myocardial infarction☆09/05/2019
- Determination of the optimal concentrations of Stannous pyrophosphate (cas 15578-26-4) for in vivo red blood cell labelling with technetium-99m09/04/2019
- NOTESStannous-Ion Quantitation in Pyrophosphate and Polyphosphate Radiopharmaceutical Kits Using Differential Pulse Polarography09/02/2019
- ReviewExploring the biological, catalytic, and magnetic properties of transition metal coordination complexes incorporating pyrophosphate09/01/2019
- Mechanistic aspects of the interaction of 99mTc in association with Stannous pyrophosphate (cas 15578-26-4) with damaged red blood cells08/31/2019
- Investigation of the interaction of hydroxyapatite with technetium in association with Stannous pyrophosphate (cas 15578-26-4)08/30/2019
- Stabilization of Stannous pyrophosphate (cas 15578-26-4) kits with gentisic acid08/29/2019
-
Health and Chemical more >